4
Changes in Ownership
Kymera Therapeutics, Inc. Filed Acc 0001209191-23-003294
Director sold 126,474 shares at an average $30.22 ($3,821,739)
From the SEC's structured data for this filing
Trades in this filing
Booth Bruce · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-11 | Sale : show line 1 in the form | −21,683 | $29.96 | $649,623 | 5,045,242 | I |
| 2023-01-11 | Sale : show line 2 in the form | −6,071 | $29.96 | $181,887 | 911,740 | I |
| 2023-01-12 | Sale : show line 3 in the form | −77,128 | $30.29 | $2,336,207 | 4,968,114 | I |
| 2023-01-12 | Sale : show line 4 in the form | −21,592 | $30.29 | $654,022 | 890,148 | I |
| Open-market sales · 126,474 sh · avg $30.22 · $3,821,739 | ||||||
Loading xslF345X03/doc4.xml…